Published in Ann Rheum Dis on April 01, 1984
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med (1989) 2.16
Safety of extended treatment with anakinra in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.74
Remission of arthritis and radiological improvement after combination therapy for non-Hodgkin's lymphoma in a patient with rheumatoid arthritis undergoing treatment with D-penicillamine. Ann Rheum Dis (1985) 1.07
Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control (2009) 1.02
Rheumatoid lymphadenopathy: a morphological and immunohistochemical study. J Clin Pathol (1990) 1.02
Heredofamilial deficiency of monocyte esterase in patients with rheumatoid arthritis. Ann Rheum Dis (1992) 0.86
Rheumatoid arthritis and malignant histiocytosis of the intestine. Ann Rheum Dis (1984) 0.84
No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan. Rheumatol Int (2014) 0.83
Lymph node hyalinisation in rheumatoid arthritis and systemic sclerosis. J Clin Pathol (1994) 0.83
Prognostic significance of paraproteinaemia in rheumatoid arthritis. Ann Rheum Dis (1991) 0.80
Rheumatological manifestations of haematological diseases. Ann Rheum Dis (1995) 0.78
Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis (1986) 0.78
Symmetrical polyarthritis is not always rheumatoid. Ann Rheum Dis (1994) 0.77
Characteristics and prognosis of colorectal cancer associated with rheumatic disease. Int Surg (2015) 0.75
Length of life and cause of death in rheumatoid arthritis. N Engl J Med (1953) 7.62
COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT. Ann Rheum Dis (1964) 5.80
Increased risk of lymphoma in sicca syndrome. Ann Intern Med (1978) 4.63
THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME. Am J Med (1964) 4.07
Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chronic Dis (1978) 3.08
Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis (1984) 2.67
The association of immune disease and malignant lymphoma. Ann Intern Med (1967) 2.17
The association of rheumatoid arthritis with plasma cell and lymphocytic neoplasms. Arthritis Rheum (1969) 1.68
Increased mortality in rheumatoid arthritis. Scand J Rheumatol (1982) 1.67
Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum (1977) 1.58
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis (1980) 1.57
Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med (1978) 1.54
Systemic lupus erythematosus and lymphoma. Lancet (1978) 1.51
Leukemia or lymphoma occurring subsequent to an autoimmune disease. Blood (1967) 1.23
Lymphoid neoplasia following connective tissue disease. Mayo Clin Proc (1979) 1.02
[Acute leukaemias after treatment using cytotoxic agents for rheumatological purpose. 19 cases among 2006 patients(author's transl)]. Nouv Presse Med (1979) 1.00
Leukaemia-like appearances in mice given penicillamine. Lancet (1976) 0.84
Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum (1994) 14.16
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum (2013) 11.18
Crystal structure of the extracellular segment of integrin alpha Vbeta3. Science (2001) 8.12
Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet (2001) 7.31
Malignancy in coeliac disease--effect of a gluten free diet. Gut (1989) 5.58
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM (1994) 5.23
Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region. BMJ (1995) 4.83
Variations in experience in obtaining local ethical approval for participation in a multi-centre study. QJM (2003) 4.53
Quantitation of thermography in arthritis using multi-isothermal analysis. I. The thermographic index. Ann Rheum Dis (1974) 3.82
Human parvovirus arthropathy. Lancet (1985) 3.76
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Breast screening programme: should the interval between tests depend on age? Lancet (1997) 3.36
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
Coeliac disease, gluten-free diet, and malignancy. Gut (1976) 3.15
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) (1981) 2.84
The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum (1995) 2.82
Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet (1987) 2.81
The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials. Rheumatology (Oxford) (2003) 2.79
Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis (1984) 2.67
Efficacy of tests used to monitor rheumatoid arthritis. Lancet (1989) 2.50
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology (2000) 2.45
Joint hypermobility leading to osteoarthrosis and chondrocalcinosis. Ann Rheum Dis (1978) 2.44
The importance of iron in rheumatoid disease. Lancet (1981) 2.44
Sensorimotor changes and functional performance in patients with knee osteoarthritis. Ann Rheum Dis (1997) 2.39
Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. Ann Thorac Surg (1999) 2.37
Early management of battle casualties in Vietnam. An analysis of 1,011 consecutive cases treated at a mobile army surgical hospital. Arch Surg (1968) 2.34
Malignancy in Crohn's disease. Gut (1980) 2.33
Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum (1997) 2.31
Development of delayed hypersensitivity to dinitrochlorobenzene in patients with Crohn's disease. Gut (1969) 2.20
The way forward for hydrotherapy. Br J Rheumatol (1993) 2.15
Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol (1993) 2.15
Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut (1994) 2.12
Cause of death in rheumatoid arthritis. Br J Rheumatol (1984) 2.12
Musculoskeletal pain is associated with a long-term increased risk of cancer and cardiovascular-related mortality. Rheumatology (Oxford) (2009) 2.09
The clinical features of chronic vitamin deficiency. A therapeutic trial in geriatric hospital patients. Gerontol Clin (Basel) (1968) 2.09
Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med (1988) 2.09
Can patients benefit from reading copies of their doctors' letters about them? Br Med J (Clin Res Ed) (1986) 2.04
The three-dimensional crystal structure of cholera toxin. J Mol Biol (1995) 2.03
A tale of seven surgeons. BMJ (2001) 2.03
Production of lymphokine mRNA by CD45R+ and CD45R- helper T cells from human peripheral blood and by human CD4+ T cell clones. J Immunol (1989) 2.03
Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol (1998) 2.00
601 octogenarians undergoing cardiac surgery: outcome and comparison with younger age groups. Ann Thorac Surg (1999) 1.96
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford) (2001) 1.96
Mortality in Crohn's disease. Gastroenterology (1981) 1.95
Synaptophysin: molecular organization and mRNA expression as determined from cloned cDNA. EMBO J (1987) 1.93
Measuring outcome in rheumatoid arthritis--which measures are suitable for routine clinical use? Br J Rheumatol (1995) 1.91
Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study. Q J Med (1976) 1.90
Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest (1997) 1.89
Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med (1984) 1.88
Cimetidine in bleeding peptic ulcer. Lancet (1979) 1.87
Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis (1984) 1.86
Gluten subfractions in coeliac disease. Lancet (1972) 1.86
Intra-articular steroids in osteoarthritis. Rheumatol Rehabil (1980) 1.85
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) (2005) 1.84
A distinct cyclin A is expressed in germ cells in the mouse. Development (1996) 1.84
Cancer morbidity in ulcerative colitis. Gut (1982) 1.82
Immunoglobulin-containing cells in human tonsils as demonstrated by immunohistochemistry. Clin Exp Immunol (1977) 1.81
Lymphoedema of the limbs as an extra-articular feature of rheumatoid arthritis. Ann Rheum Dis (1990) 1.79
Classical versus non-renal Wegener's granulomatosis. Q J Med (1994) 1.79
Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum (1999) 1.78
Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells. Transplantation (2001) 1.78
Serum biochemical values in rheumatoid disease. Ann Rheum Dis (1971) 1.77
Crystal structure of cobra-venom phospholipase A2 in a complex with a transition-state analogue. Science (1990) 1.77
Hepatitis-B antibody in polymyalgia Rheumatica. Lancet (1975) 1.77
Leukemia following chemotherapy for ovarian cancer. N Engl J Med (1990) 1.76
Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis. BMJ (1992) 1.72
Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol (1998) 1.72
Mortality in Crohn's disease. Lancet (1970) 1.71
Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthritis Rheum (2001) 1.71
The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum (2001) 1.71
The long-term effects of treating rheumatoid arthritis. J R Coll Physicians Lond (1983) 1.70
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis (2007) 1.68
Hypothalamo-pituitary-adrenal function in patients on long-term adrenocorticotrophin therapy. Ann Rheum Dis (1968) 1.68
The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol (1994) 1.67
Raised serum alkaline phosphatase in rheumatoid disease. An index of liver dysfunction? Ann Rheum Dis (1970) 1.67
In vitro responses to a 65-kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients. J Immunol (1989) 1.67
Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol (1996) 1.67
IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy. Clin Exp Immunol (1981) 1.66
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. Ann Rheum Dis (1992) 1.65
The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. American Rheumatism Association. J Rheumatol (1998) 1.63
Frequency of occurrence, mode of development, and significance or rice bodies in rheumatoid joints. Ann Rheum Dis (1982) 1.62
Joint counts in routine practice. Rheumatology (Oxford) (2003) 1.62
Autoimmune haemolytic anaemia and mefenamic acid therapy. Br Med J (1968) 1.62
Failed elective percutaneous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years. Circulation (1990) 1.62
Phosphoinositides in mitogenesis: neomycin inhibits thrombin-stimulated phosphoinositide turnover and initiation of cell proliferation. Cell (1985) 1.62
Cloning and expression of the 58 kd beta subunit of the inhibitory glycine receptor. Neuron (1990) 1.61